Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02650245 · ClinicalTrials.gov registry record · NA
Breath and Blood Ammonia Response to an Oral Protein Challenge
A NA study, sponsored by St. Luke's Hospital and Health Network, Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT02650245 is a NA study that has completed, run by St. Luke's Hospital and Health Network, Pennsylvania. The registered enrollment target is 12 participants.
The verdict
NCT02650245, a NA study, has completed, sponsored by St. Luke's Hospital and Health Network, Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The investigators specific aim is to evaluate the changes in breath ammonia in comparison to blood ammonia and other physiologic markers after a moderate oral protein challenge in healthy subjects and subjects with liver cirrhosis.
Interventions
- DIETARY_SUPPLEMENT EAS Myoplex Protein Drink + 10gm lactulose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2015-10 |
| Est. Completion | 2016-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02650245
The ClinicalTrials.gov registry entry for NCT02650245 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Luke's Hospital and Health Network, Pennsylvania, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EAS Myoplex Protein Drink + 10gm lactulose is the first listed.
NCT02650245 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02650245 about?
NCT02650245 is a clinical study titled "Breath and Blood Ammonia Response to an Oral Protein Challenge". The investigators specific aim is to evaluate the changes in breath ammonia in comparison to blood ammonia and other physiologic markers after a moderate oral protein challenge in healthy subjects and subjects with liver cirrhosis.
What is the current status of trial NCT02650245?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2015-10. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02650245?
The interventions under investigation include: EAS Myoplex Protein Drink + 10gm lactulose (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02650245?
This trial is sponsored by St. Luke's Hospital and Health Network, Pennsylvania, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.